ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,294.10
-0.42%
S&P ASX All Technology
3,845.90
-0.28%
Brent Oil
79.285
0.00%
US Dollar vs AUD
1.6276
0.00%
Bitcoin
94,551.31
-0.16%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Stevanato Group SpA (STVN) Share Price

Stevanato Group SpA

Stevanato Group SpA (STVN)

NYSE
22.94
-1.00
(-4.18%)
Closed 11 January 8:00AM
Delayed by 15 minutes
22.94
0.00
(0.00%)
After Hours: 9:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
22.94
Bid
-
Offer
-
Volume
361,771
22.18 Day's Range 24.54
16.56 52 Week Range 34.73
Market Cap
6.78B
Previous Close
23.94
Open
24.54
Last Trade
34948
@
22.94
Last Trade Time
Financial Volume
US$ 8,391,355
VWAP
23.1952
Average Volume (3m)
474,618
Shares Outstanding
295,540,036
Dividend Yield
0.23%
PE Ratio
46.57
Earnings Per Share (EPS)
0.49
Revenue
1.1B
Net Profit
145.63M

About Stevanato Group SpA

Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire ... Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.stevanatogroup.com/en
Headquarters
Pioltello, Lombardy, Ita
Founded
-
Stevanato Group SpA is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker STVN. The last closing price for Stevanato was US$23.94. Over the last year, Stevanato shares have traded in a share price range of US$ 16.56 to US$ 34.73.

Stevanato currently has 295,540,036 shares in issue. The market capitalisation of Stevanato is US$7.08 billion. Stevanato has a price to earnings ratio (PE ratio) of 46.57.

Ask ADVFN Intelligence (AI)

STVN Latest News

More News

Stevanato Group to Present at Upcoming Investor Conference

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that...

08 January 2025
Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 November 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

15 November 2024
Edgar (US Regulatory)

Stevanato Group to Present at Upcoming Investor Conferences

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that...

11 November 2024
Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

06 November 2024
Edgar (US Regulatory)

Stevanato Group Reports Financial Results for the Third Quarter of 2024

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries...

05 November 2024
Business Wire

Stevanato Group to Report Third Quarter 2024 Financial Results on November 5, 2024

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries...

23 October 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.52.2281639928722.4424.992232578323.84185773CS
4-0.09-0.39079461571923.0324.9920.0842857922.41304654CS
124.7325.974739154318.2124.9917.1247461820.60512483CS
263.7519.54142782719.1924.9917.1251536520.3431122CS
52-4.44-16.216216216227.3834.7316.5650096822.41629943CS
1565.1428.876404494417.836.313.35537529022.27282821CS
2606.2937.777777777816.6536.313.35540171222.3386633CS

STVN - Frequently Asked Questions (FAQ)

What is the current Stevanato share price?
The current share price of Stevanato is US$ 22.94
How many Stevanato shares are in issue?
Stevanato has 295,540,036 shares in issue
What is the market cap of Stevanato?
The market capitalisation of Stevanato is USD 7.08B
What is the 1 year trading range for Stevanato share price?
Stevanato has traded in the range of US$ 16.56 to US$ 34.73 during the past year
What is the PE ratio of Stevanato?
The price to earnings ratio of Stevanato is 46.57
What is the cash to sales ratio of Stevanato?
The cash to sales ratio of Stevanato is 6.19
What is the reporting currency for Stevanato?
Stevanato reports financial results in EUR
What is the latest annual turnover for Stevanato?
The latest annual turnover of Stevanato is EUR 1.1B
What is the latest annual profit for Stevanato?
The latest annual profit of Stevanato is EUR 145.63M
What is the registered address of Stevanato?
The registered address for Stevanato is VIA MOLINELLA 17, PIOLTELLO, LOMBARDY, 35017
What is the Stevanato website address?
The website address for Stevanato is www.stevanatogroup.com/en
Which industry sector does Stevanato operate in?
Stevanato operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMPXAmprius Technologies Inc
US$ 3.58
(18.15%)
9.45M
EVCEntravision Communications Corp
US$ 2.65
(16.23%)
1.23M
SSLSasol Ltd
US$ 5.07
(14.71%)
2.45M
OPFIOppFi Inc
US$ 9.285
(12.96%)
4.96M
SVVSavers Value Village Inc
US$ 10.4525
(11.55%)
956.76k
ALURAllurion Technologies Inc
US$ 3.80
(-47.51%)
229.92k
MCYMercury General Corp
US$ 48.68
(-19.80%)
3.49M
SESSES AI Corporation
US$ 1.265
(-18.39%)
18.16M
STZConstellation Brands Inc
US$ 181.81
(-17.09%)
8.7M
GROVGrove Collaborative Holdings Inc
US$ 1.46
(-17.05%)
885.79k
FUBOfuboTV
US$ 5.11
(-4.49%)
98.22M
QBTSD Wave Quantum Inc
US$ 5.765
(-5.49%)
88.81M
FFord Motor Company
US$ 9.65
(-0.92%)
73.34M
PCGPG&E Corporation
US$ 17.16
(-10.86%)
72.59M
IONQIonQ Inc
US$ 32.33
(6.88%)
68.29M

STVN Discussion

View Posts
weedtrader420 weedtrader420 3 years ago
STVN $50 TARGET PRICE WOOHOOOOOO
👍️0
Glider549 Glider549 3 years ago
Picks and shovels!
Love it!
👍️0
weedtrader420 weedtrader420 3 years ago
Owns 80% of the vaccine Bottling business They make almost every vaccine bottle
👍️0

Your Recent History

NYSE
STVN
Stevanato
NASDAQI
BSMS
Invesco BulletShares 202...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads